Inhibitors of Src family kinases, inducible nitric oxide synthase, and NADPH oxidase as potential CNS drug targets for neurological diseases

<p></p><p>The above plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p><p><br></p> <p> </p> <p>© Springer Nature Switzerland AG 2021.</p><br><p></p>